Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 most profitable NASDAQ stocks to buy now. On June 9, Regeneron Pharmaceuticals and Sanofi (NASDAQ:SNY) announced promising interim results ...

Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced detailed positive results from a late-stage study evaluating asthma drug, Dupixent.

Regeneron Pharmaceuticals (REGN) and Sanofi ... 120 patients with atopic dermatitis and skin of color were treated with Dupixent every two weeks using a weight-based dosing regimen.

Regeneron, Sanofi’s hotly tipped atopic dermatitis drug dupilumab accepted for review at EMA By Nick Paul Taylor Dec 8, 2016 5:53am eczema EuroBiotech Report Regeneron Pharmaceuticals Sanofi ...

Sanofi and Regeneron want to stop bullying around atopic dermatitis. So this fall, the drugmaker partners launched the “Agents of Change” AD Challenge and asked people to submit ideas. After ...

Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...

Regeneron Pharmaceuticals and Sanofi said their experimental drug for a debilitating skin condition called atopic dermatitis met all of its major treatment targets in two late-stage studies, a key ...

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi SA (SNYNF, SNY) announced Saturday positive data from long-term pivotal phase 3 CHRONOS study of DUPIXENT (dupilumab) in moderate-to ...

Regeneron Pharmaceuticals Inc. and Sanofi SA said Tuesday the U.S. Food and Drug Administration has approved Dupixent Injection, the only biologic medicine approved for treating adults with ...

Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY came up with positive detailed results from a phase III trial on Dupixent for the indication of atopic dermatitis in adolescents at in ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 most profitable NASDAQ stocks to buy now. ... Atopic dermatitis is a chronic skin condition driven by type 2 inflammation, ...